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The incorporation of the -amino acid residues into specific positions in the strands and -turn segments of
peptide hairpins is being systematically explored. The presence of an additional torsion variable about the
C()C() bond () enhances the conformational repertoire in -residues. The conformational analysis of
three designed peptide hairpins composed of /-hybrid segments is described: Boc-Leu-Val-Val-DPro-Phe-
Leu-Val-Val-OMe (1), Boc-Leu-Val-Val-DPro-Gly-Leu-Val-Val-OMe (2), and Boc-Leu-Val-Phe-Val-DPro-
Gly-Leu-Phe-Val-Val-OMe (3). 500-MHz 1H-NMR Analysis supports a preponderance of -hairpin
conformation in solution for all three peptides, with critical cross-strand NOEs providing evidence for the
proposed structures. The crystal structure of peptide 2 reveals a -hairpin conformation with two -residues
occupying facing, non-H-bonded positions in antiparallel -strands. Notably, Val(3) adopts a gauche
conformation about the C()C() bond (65) without disturbing cross-strand H-bonding. The crystal
structure of 2, together with previously published crystal structures of peptides 3 and Boc-Phe-Phe-DPro-Gly-
Phe-Phe-OMe, provide an opportunity to visualize the packing of peptide sheets with local −polar segments×
formed as a consequence of reversal peptide-bond orientation. The available structural evidence for hairpins
suggests that -residues can be accommodated into nucleating turn segments and into both the H-bonding and
non-H-bonding positions on the strands.
Introduction. ± The stereochemistry of polypeptide chains composed of -amino
acid residues has been extensively investigated since Pauling×s remarkable insights led
to the elucidation of the -helix and -sheet structures [1] [2]. The recognition by
Ramachandran and co-workers that stereochemically allowed conformations of
polypeptide chains may be conveniently analyzed in torsion angle (, ) space, with
each residue exhibiting two degrees of freedom, was a major advance in the
development of polypeptide stereochemistry [3] [4]. The focus of much work over
the past several decades has been on polypeptides composed of -amino acids, with
natural proteins being pre-eminent examples [5]. Considerable attention has also been
paid to the use of stereochemically constrained amino acids and templates in the design
of folded polypeptides, with ,-restrictions being imposed by backbone modifications
like substitution, chirality reversal, and cyclization [6 ± 8]. In principle, the introduction
of additional degrees of torsional freedom into the polypeptide backbone by insertion
of methylene groups must expand the conformational repertoire. Early work on
polyamides related to the nylons did indeed suggest the possibility of novel folded
structures for poly--amino acids, hitherto unknown in the area of poly--amino acids
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[9] [10]. The structural characterization of the conformations exhibited by peptides
composed of -amino acids received a major thrust when Seebach and co-workers
initiated a comprehensive and incisive analysis of the stereochemistry of -peptide
chains [11 ± 15]. The expanded range of novel polypeptide structures that could be
achieved in poly--peptides was vividly illustrated in the crystallographic character-
ization of the 12-helix and 14-helix, in the structures of oligomers of trans-2-
aminocyclopentanecarboxylic acid (ACPC) and trans-2-aminocyclohexanecarboxylic
acid (ACHC), respectively, by Gellman and co-workers [16 ± 19]. The major lessons
that have been learnt, thus far, from the growing body of work on -peptides are: i)
Novel H-bonding patterns, with reversal of directionality of donors and acceptors and
reversal of the sense of helix twist, may be obtained in -peptide helices. ii) −Polar× -
sheets are formed by -peptides with a net dipole moment perpendicular to the strand
direction in contrast to sheets formed by -peptides.
As part of a program to develop the use of /- and /-hybrid sequences in
peptide design, we have been exploring the consequences of incorporating -residues
and higher homologues as guests into host -amino acid sequences [20]. This approach
is of relevance in the generation of biologically active peptide analogs exhibiting
resistance to proteolysis, with susceptible cleavage sites modified by insertion of -
residues [21] [22].
The discussion of the conformational properties of -residues is based on three
degrees of conformational freedom: (NC()), (C()C()), and (C()CO).
The ,,-nomenclature [23] [24] permits labeling of torsion angles sequentially from
the N-terminus of the peptide chain, allowing a direct comparison with the vast body of
conformational information on -peptides. Fig. 1 shows a distribution of available -
residue conformations in a 3-dimensional ,,-diagram. In general,  values of  60
and 180 are observed. The gauche conformers are generally obtained in folded helical
and turn structures while the trans form is seen in cases of extended strands. In cyclic
-amino acids, like ACPC,  values as large as 90 are observed.
In this report, we specifically address the issue of inserting -residues at the turn and
strand positions of peptide hairpins. Fig. 2,a schematically illustrates the hairpin
structure. In principle, four distinct sites for -residue substitution may be considered.
These are the i 1 and i 2 positions of the -turn and the H-bonding and non-H-
bonding positions on the pair of antiparallel strands. Peptide hairpins have been
successfully nucleated with the DPro-Gly -turn motif (Fig. 2,b). In the area of -
peptides, two potential hairpin-nucleating motifs have been reported in the literature.
Seebach et al. have suggested the C10 H-bonded structure (Fig. 2,c) as a hairpin
nucleator [25]. An isolated C10-turn structure has been crystallographically charac-
terized in a model tripeptide [26]. Gellman and co-workers have advanced the use of
heterochiral dinipecotic acid (1-(3-piperidinylcarbonyl)piperidine-3-carboxylic acid)
segments, which form a C12 H-bonded turn facilitating antiparallel-hairpin formation
[27]. We have previously established the structures of crystalline peptide hairpins that
contain -amino acids in the strand positions. In this report, we describe the structural
characterization of three ,-hybrid peptides, which contain -residues at chosen
positions: Boc-Leu-Val-Val-DPro-Phe-Leu-Val-Val-OMe1) (1), Boc-Leu-Val-Val-
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1) 3-(S)-Homophenylalanine is abbreviated as Phe for simplicity.
DPro-Gly-Leu-Val-Val-OMe2)3) (2), and Boc-Leu-Val-Phe-Val-DPro-Gly-Leu-
Phe-Val-Val-OMe (3). The anticipated hairpin forms are illustrated in Fig. 3. The
results presented here are compared with those for two previously studied peptides:
Boc-Leu-Val-Val-DPro-Gly-Leu-Val-Val-OMe (4) and Boc-Phe--Phe-DPro-Gly-
Phe-Phe-OMe (5).
Peptide 4 is the canonical -peptide hairpin, whose conformation has been
established in both solution [28] [29] and in the solid state [30]. Peptide 5 has been
crystallographically characterized [31].
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Fig. 1. Distribution of crystallographically observed -residues conformation in ,,-conformational space. The
shaded planes highlight gauche conformations of -residues about the C()C() bond. *: Observation for the
chiral acyclic -amino acid, -glycine (referred to in the early literature as -alanine, correctly designated as -
glycine); in the case of achiral peptides crystallizing in centric space groups, one sign of the dihedral angles was
arbitrarily taken. : Chiral acyclic -amino acids.  (yellow): Chiral cyclic -amino acids. : Nipecotic acid
( piperidine-3-carboxylic acid) (this is shown separately because the constraints of cyclization restrict both 
and  values [27]).  (red): Idealized 14- and 12-helix structures.
2) 3-(R)-Homovaline (Val) was generated from (S)-valine. Note the formal change of configuration
assignment upon homologation [14].
3) 3-(S)-Homoleucine (Leu) was generated from (S)-leucine.
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Fig. 3. Schematic representation of proposed -hairpins of a) peptide 1, b) peptide 2, and c) peptide 3. The
observed NOEs, indicated by double edged arrows, determine the -hairpin conformations.
Fig. 2. a) Definition of the -turn, H-bonding, and non-H-bonding strand positions in -hairpins ; possible turn-
nucleating structures: b) - -Turn (cf. DPro-Gly with a 4 1 H-bonded structure). c) Ten-membered (C10) turn
formed by a - segment (1 2 H-bond). d) Twelve-membered (C12) turn of - segment (4 1 H-bond, cf.
dinipecotic acid (1-(3-piperidinylcarbonyl)piperidine-3-carboxylic acid [27]).
Results and Discussion. ± NMR Analysis of Peptide 1. Sequence-specific assign-
ments were achieved by means of a combination of TOCSYand ROESYexperiments.
The chemical shifts are summarized in Table 1. Fig. 4 shows partial sections of the
ROESY spectrum of 1. It is evident that strong sequential, inter-residue dN-
connectivities were observed, while dNN-sequential connectivities are weak or absent.
This suggests that extended conformations are favored for residues 1 ± 3 and 6 ± 8. A
weak dNN-connectivity is indeed observed between NH(Phe(5)) and NH(Leu(6))
protons supporting chain reversal. Most importantly, the cross-strand NOEs dNN (1/8)
and dNN (3/6) are observed (Fig. 4), which are characteristic of a registered pair of
antiparallel strands (Fig. 3). In addition, the d (2/7) is also observed despite the
limited chemical-shift dispersion of the resonances. The NMR data strongly support a
major population of -hairpin conformations in peptide 1.
NMR Analysis of Peptide 2. Peptide 2 contains Val at position 3 and Leu at
position 6, which should occupy the facing H-bonding positions in the putative hairpin
structure (Fig. 3). In CDCl3, 2 yielded a poorly dispersed 1H-NMR spectrum. Further
analyses were, therefore, carried out in CD3OD. Resonances were readily assigned by
means of a combination of TOCSY and ROESY experiments. The chemical shifts
are summarized in Table 2. Relevant sections of the ROESY spectrum are illustrated
in Fig. 5. A strong dNN (5/6) connectivity confirms that Gly(5) adopts a local
helical conformation, consistent with occupying a -turn position. A cross-strand dNN
(2/7) NOE also supports the hairpin conformation shown in Fig. 3. Strong sequential
inter-residue dN connectivities are observed for Val(2) ±Val(7) strand residues.
The strong NOE between NH(Val(7)) and HC()(Leu(6)) protons provides
further support for the proposed conformation. A dN (i,i 2) NOE is also observed
between HC()(Pro) and NH(Leu(6)) (Fig. 5,a), which is suggestive of a
type-I structure. The dNN (1/2) NOE prominently seen in Fig. 5,b has been generally
observed in peptide hairpins and is likely to be an indicator of fraying of strands at
the termini.
NMR Analysis of Peptide 3. In this designed decapeptide hairpin, the two Phe
residues have been inserted into the sequence of the canonical -hairpins 4, such that
they occupy facing non-H-bonding positions. Since well-dispersed NMR spectra of
peptide 3 were obtained in CD3OD, all subsequent analyses were carried out in this
solvent. Peptide 3 also exhibits extremely good dispersion in CDCl3. Resonance
assignments were possible by means of a combination of TOCSY and ROESY
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Table 1. 1H-NMR (500 MHz) Chemical Shifts ( in ppm) for Peptide 1 at 300 K in CDCl3
Residue NH HC() HC() Others
Leu(1) 5.68 4.15 1.65 1.55 (HC()); 0.90 (2 Me())
Val(2) 6.63 4.78 1.94 0.6, 0.93 (2 Me())
Val(3) 8.39 4.61 2.05 0.91 (2 Me())
DPro(4) 4.30 2.10 1.89, 1.98 (CH2()); 3.53, 3.72 (CH2())
Phe(5) 6.49 2.50, 2.59 4.09 2.90, 2.95 (CH2()); 7.10 ± 7.26 (arom. H)
Leu(6) 7.43 4.65 1.81 1.62 (HC()); 0.95 (2 Me())
Val(7) 6.94 4.69 2.02 0.98 (2 Me())
Val(8) 8.09 4.59 2.18 0.94 (2 Me())
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Fig. 4. Partial 500-MHz ROESY spectrum of peptide 1 in CDCl3 at 300 K. a) HC()NH NOEs and b)
NHNH NOEs. Cross-peaks are labelled with residue numbers. The long-range NOEs diagnostic of -
hairpin conformations are boxed.
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Fig. 5. Partial 500-MHz ROESY spectrum of peptide 2 in CD3OD at 300 K. a) HC()NH NOEs and b)
NHNH NOEs. Cross-peaks are labelled with residue numbers. The long-range NOEs diagnostic of -
hairpin conformations are boxed.
experiments. The chemical shifts are listed in Table 3. Fig. 6 shows sections of the
ROESY spectrum illustrating conformationally relevant NOEs. The -hairpin struc-
ture is supported by the observation of dNN (4/7) and dNN (1/10) connectivities. Further
support for the hairpin comes from the observation of a strong d (2/9) NOE (not
shown) and the observation of a cross-strand NOE between NH(Phe(3)) and
HC()(Phe(8)).
Circular Dichroism. Fig. 7 compares the far-UV/CD spectra of peptides 1 ± 4. In all
cases, a strong negative band between 218 and 220 nm is observed, a feature seen in
other peptide hairpins. The spectrum of peptides 3 shows evidence for additional bands
seen as a shoulder at ca. 230 nm, presumably due to aromatic chromophores. Indeed,
earlier studies of peptide hairpins have shown that far-UV/CD spectra can be
considerably distorted as a consequence of through-space interactions between
aromatic groups [32].
Crystallographic Studies. Single crystals suitable for X-ray diffraction were obtained
for the peptides 2 and 3, but peptide 1 has, thus far, remained recalcitrant to
crystallization. The structure of peptide 3, which adopts a -hairpin conformation in
crystals, has been reported earlier [33]. The crystal structure of peptide 2 is described
below.
Crystal Structure of Peptide 2. Fig. 8 shows the conformation of peptide 3 in the
crystal. Backbone and side-chain torsion angles and H-bond parameters are
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Table 2. 1H-NMR (500 MHz) Chemical Shifts for Peptide 2 at 300 K in CD3OD
Residue NH HC() HC() Others
Leu(1) 6.79 4.13 1.68 1.56 (HC()); 0.96 (2Me())
Val(2) 7.81 0.13 2.03 0.96 (2 Me())
Val(3) 7.84 2.58, 2.68 4.31 1.80 (HC()); 0.98 (2 Me())
DPro(4) 4.25 2.23 1.99, 2.12 (CH2()); 3.65, 3.73 (CH2())
Gly(5) 8.43 3.69, 3.89
Leu(6) 7.61 2.42, 2.68 4.42 1.58 (CH2()); 1.28 (HC()); 0.90 (2 Me())
Val(7) 8.29 4.26 2.08 1.0 (2 Me())
Val(8) 8.32 4.35 2.15 0.98 (2 Me())
Table 3. 1H-NMR (500 MHz) Chemical Shifts for Peptide 3 at 300 K in CD3OD
Residue NH HC() HC() Others
Leu(1) 6.80 4.18 1.72 1.69 (HC()); 0.96 (2 Me())
Val(2) 7.74 4.55 1.98 0.90 (2 Me())
Phe(3) 8.36 2.35, 2.95 4.68 2.7, 2.75 (CH2()); 7.10 ± 7.26 (arom. H)
Val(4) 8.48 4.66 2.14 1.05 (2 Me())
DPro(5) 4.28 2.22 1.99, 2.12 (CH2()); 3.75, 3.80 (CH2())
Gly(6) 8.56 3.70, 3.88
Leu(7) 8.20 4.41 1.79 1.69 (HC()); 0.95 (2 Me())
Phe(8) 8.01 2.18, 2.35 4.32 2.69, 2.75 (CH2()); 7.10 ± 7.26 (arom. H)
Val(9) 8.03 4.78 2.05 1.0 (2 Me())
Val(10) 8.62 4.35 2.18 0.98 (2 Me())
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Fig. 6. Partial 500-MHz ROESY spectrum of peptide 3 in CD3OD at 300 K. a) HC()NH NOEs and b)
NHNH NOEs. Cross-peaks are labelled with residue numbers. The long-range NOEs diagnostic of -
hairpin conformations are boxed.
summarized in Tables 4 and 5, respectively. The molecule forms a -hairpin with four
cross-strand H-bonds. The DPro-Gly segment occurs in a type-I conformation. The
inspection of backbone torsion angles in Table 4 reveals that the Val(3) residue adopts
an unusual gauche conformation (365). Normally, in a strand position, a trans
conformation ( 180) would be anticipated for the -residues. An almost
completely extended value is obtained for 3 (175) of Val(3). Clearly, the
distortion at 3 has been compensated by a corresponding change in 3 to maintain an
antiparallel -sheet. It should be noted that, for -residues in the strand positions of
hairpins, values of , , and  are generally in the range of  120 20, 150 30,
and  120 20, respectively, based on a limited number of known crystalline
hairpins, containing both - and -amino acid residues.
Comparison of -Hairpin-Containing -Residues. The availability of crystalline
structures for peptide 2 (this study), 3 [33], and 4 [31] permits a comparison of
conformational features and hairpin-packing arrangements. These, in turn, may be
compared with the previously determined structure of the -peptide -hairpin 4. In
peptide 4 (containing all -amino acids in the strand) and 5 (-amino acids), the
DPro-Gly segment adopts the type-II conformation (idealized torsion angles are
Pro60, Pro120, Gly80, and Gly 0). In contrast, for strands
containing both - and -amino acids, as in the case of peptide 2 and 3, a type-I -
turn conformation (idealized torsion angles are Pro60, Pro30, Gly90,
and Gly 0) is obtained for DPro-Gly segments. A view of the molecular
conformations observed in crystals of the peptides 2, 3, and 5 is shown in Fig. 9.
Notably, in the -hairpins in proteins, necessarily composed of only -amino acids, the
extent of strand twist is determined by the nature of the nucleating -turn. The hairpins
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Fig. 7. Circular dichroism spectra of peptides 1 (), 2 (), 3 (), and 4 () in the far-UV region in MeOH
nucleated by the type-II turns are flatter, while those forming type-I turns show a
greater degree of strand twist [34].
The assemblies of -sheets from individual molecules also separate into two general
groups. Hairpins 4 and 5 assemble into extended -sheets by simple lateral translation
of molecules and intermolecular H-bonding, as shown in Fig. 10. The main difference
between the sheets of 4 and 5 are the directions of the NH ¥¥¥OC H-bonds. In 4, the
direction alternates along the strands, whereas in 5 all the CO moieties point to the
right and the direction of all H-bonds is the same. The unique directionality of the H-
bonds implies a distinct polarity for the sheets [18] [25] [27].
The assembly of hairpins with mixed /-residues, as exemplified by peptides 2 and
3, falls into a different pattern (Fig. 11). Neighboring hairpins are related by a 2-fold
rotation axis for 2 and a 2-fold screw axis for 3. In each case, the -turns in adjacent
molecules alternate between top and bottom. The direction of individual CO
moieties depends upon the position of the -residues in the strand, hence, the polar
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Fig. 8. ORTEP View of -hairpin of 2. Thermal ellipsoids are at 20% probability and the size of the H-atoms is
arbitrary. Dotted lines represent H-bonds. W1 and W1a are symmetry-related H2O molecules.
regions or bonds are scattered. In these four structures, the NH ¥¥¥OC H-bonds, both
inside a hairpin and between hairpins, form loops of 10- or 14-membered rings, except for
one 12-membered ring in 3 that contains the N(2)H ¥¥¥O(6b) and N(8b)H ¥¥¥O(2)
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Table 4. Torsional Angles in Peptide 2
Residue Backbone Side chains
Angle [] Angle []
Leu(1) 1  108 	11  59
1  52 	12  47, 176
1  178
Val(2) 2  132 	21  37,  178
2  131
2  178
Val(3) 3  131 	31  73,  177
3  65
3  175
3  171
DPro(4) 4  70 	41  20
4  17 	42  31
4  174 	43  11
	44  26
C()NC()C()  5
Gly(5) 5  73
5  17
5  176
Leu(6) 6  136 	61  71
6  178 	62  67, 173
6  115
6  179
Val(7) 7  121 	71  64,  174
7  126
7  172
Val(8) 8  109 	81  79,  69
8  1
8  179
Table 5. H-Bonds in Peptide 2
H-Bond type Donora) Acceptora) d(D ¥¥¥A) [ä] d(H ¥¥¥A) [ä]b) D ¥¥¥OC angle []
Intramol. N(1) O(7) 2.81 1.93 157
Intramol. N(2) O(7) 3.15 2.30 140
Intermol. N(3) O(1)c) 2.96 2.08 143
Intermol. N(5) O(4)d) 3.08 2.39 156
Intramol. N(6) O(3) 2.84 1.98 137
Intramol. N(7) O(2) 2.85 2.01 148
Intermol. N(8) O(6)e) 2.91 2.04 156
Solv.-pept. W1 O(5) 2.69 123
Solv-pept. W1 O(0)f) 2.80 149
a) For assignments, see Fig. 8. b) H-Atoms were placed in idealized positions with NH 0.90 ä. c) At
symmetry equivalent  x,  y,  z. d) At symmetry equivalent 1/2 x, 1/2 y,  z. e) At symmetry
equivalent  x,  y, 1 z. f) At symmetry equivalent 1/2 x, 1/2 y,  z.
H-bonds. All H-bonds are quite normal in length and direction. Table 5 lists the H-bond
parameters for 2.
The structures of hairpins 1 ± 5 suggest that variations in the location of -residues in
the sequence of peptides that tend to form -sheets can lead to -sheets that have
individualized polar properties.
Conclusions. ± Results of our ongoing studies on /-hybrid peptides suggest that -
residues can be accommodated into the turn and strand positions of the -hairpins
derived from parent -amino acid sequences. NMR and crystallographic evidence
for hairpin structures in several model sequences provides strong support for this
conclusion. The insertion of -residues into extended strands alters the polarity of the
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Fig. 9. Molecular structures of peptides 3 [33], 5 [31], and 2 (this study) determined by X-ray diffraction. These
figures were generated by means of MOLMOL, with atomic coordinates obtained from X-ray data.
Fig. 10. a) Extended -sheet of 4. NH ¥¥¥OC H-bonds alternate directions and produce an apolar sheet [30].
b) Extended -sheet of peptide 5. NH ¥¥¥OCH-bonds all point in the same direction and produce a polar sheet
[31].
H-bond pattern both within the molecule and in the crystals. The orientation of the side
chains with respect to the sheet scaffold are also altered. The insertion of chiral and
multiply-substituted -amino acids into peptides of defined structure is likely to
provide many new opportunities for the creation of novel structures.
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Experimental Part
1. General. Abbreviations: Boc (tert-butoxy)carbonyl, DCCN,N-dicyclohexylcarbodiimide, HOBT
1-hydroxybenzotriazole. THF and Et3N were refluxed over Na and distilled. Boc-amino acids were prepared
with Boc anhydride. Diazomethane (CH2N2) gas was generated from N-methyl-(4-methylphenyl)-N-nitro-
sosulfonamide. DMF was distilled over P2O5. Anal. HPLC: Shimadzu SPD-6A HPLC system (variable
wavelength monitor). MPLC: B¸chi 684 with Knauer UV monitor. Semiprep. HPLC: Hewlett-Packard
Series 1100 system. CD: Jasco J-715, 1-mm cell length. NMR: Bruker DRX-500. MALDI-TOF-MS: Kratos.
2. Synthesis of -Amino Acids. 2.1. General Procedure. According to literature procedures [11] [35], the
Boc-protected amino acid (10 mmol) was dissolved in anh. THF (25 ml) and then cooled to15. Et3N (1.25 ml,
1 equiv.) and ClCOOEt (1.25 ml, 1 equiv.) were added to the soln. After 30 min, a sat. soln. of CH2N2 in CHCl3
(650 ml) was added until intensive greenish-yellow color persisted. The mixture was then stirred for 5 h. After
aq. workup by successive washing with 5% HCl (3 50 ml), 5% NaHCO3 (3 50 ml), and brine (30 ml), the
org. layer was concentrated under reduced pressure. The crude product was subjected toWolff rearrangement.
As reported in [36], the diazoketone (10 mmol) was dissolved in THF (25 ml) with the addition of 10%
(v/v) H2O and then cooled to 15. The soln. of AcOAg (1 mmol) in Et3N (11 mmol) was added, and the
resulting mixture was stirred for 3 h. The progress of the reaction was monitored by TLC (CHCl3/MeOH/AcOH
40 :2 : 1 (v/v)). The solvent was removed under reduced pressure, and the residue was diluted with H2O. The aq.
phase was extracted with AcOEt, and the resulting colorless phase was adjusted to pH 2 with 2 HCl and
extracted with AcOEt. The AcOEt extracts were washed with brine, dried (Na2SO4), and the solvent was
removed under reduced pressure.
2.2. (S)-3-{[(tert-Butoxy)carbonyl]amino}-4-phenylbutanoic Acid (Boc-Phe). According to 2.1, reaction
with Boc-(S)-phenylalanine (7.95 g, 30 mmol) gave, after aq. workup, 7.5 g (86%) of the corresponding
diazoketone as yellow crystalline needles.
According to 2.1, reaction with tert-butyl N-[(S)-1-benzyl-3-diazenyl-2-oxopropyl]carbamate (7.2 g,
25 mmol) gave, after workup, 5.3 g (76%) of Boc-Phe as a white solid. 1H-NMR (80 MHz, CDCl3): 1.42
(s, t-Bu); 2.42 (d, CH2); 2.86 (d, CH2); 4.45 (m, CH), 7.25 (s, arom. H).
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Fig. 11. a) Mixed /-residues in the extended -sheet of peptide 2 with scattered polar regions. b) Mixed /-
residues in the extended -sheet of peptide 3 with a central polar band [33].
2.3. (R)-3-{[(tert-Butoxy)carbonyl]amino}-4-metylpentanoic Acid (Boc-Val). According to 2.1, reaction
with Boc-(S)-valine (8.68 g, 40 mmol) gave, after aq. workup, 8.3 g (86%) of the corresponding diazoketone as
yellow crystalline needles.
According to 2.1, reaction with tert-butyl N-[(S)-1-diazenyl-1-isopropyl-2-oxopropyl]carbamate (8.0 g)
gave, after workup, 5.6 g (73%) of Boc-Val as a white solid. 1H-NMR (80 MHz, CDCl3): 0.92 (d, 2 Me); 1.38
(s, t-Bu); 2.22 (m, CH); 2.36 (d, CH2); 4.20 (m, CH).
2.4. (S)-3-{[(tert-Butoxy)carbonyl]amino}-5-metylhexanoic Acid (Boc-Leu). According to 2.1, reaction
with Boc-(S)-leucine (9.24 g, 40 mmol) gave, after aq. workup, 8.6 g (85%) of the corresponding diazoketone as
yellow crystalline needles.
According to 2.1, reaction with tert-butyl N-[(S)-1-(2-diazenyl-1-oxoethyl)-3-methylbutyl]carbamate
(8.3 g) gave, after workup, 6.2 g of Boc-Leu as a white solid. 1H-NMR (80 MHz, CDCl3): 0.90 (d, 2 Me);
1.38 (s, t-Bu); 1.56 (m, CH); 1.65 (m, CH2); 2.45 (d, CH2); 4.20 (m, CH).
2.5. Methyl (R)-3-{[(tert-Butoxy)carbonyl]amino}-4-metylpentanoate (Boc-Val-OMe). Boc-Val (2.31 g,
10 mmol) was dissolved in MeOH (5 ml) and diluted with 100 ml of Et2O. CH2N2 was passed to the soln. until it
turned yellow. Et2O was evaporated under reduced pressure to yield 2.25 g (92%) of Boc-Val-OMe.1H-NMR
(80 MHz, CDCl3): 0.90 (d, 2 Me); 1.38 (s, t-Bu); 2.22 (m, CH); 2.36 (d, CH2); 3.61 (s, OMe); 4.20 (m, CH).
2.6. Methyl (S)-3-{[(tert-Butoxy)carbonyl]amino}-4-phenylbutanoate (Boc-Phe-OMe). Synthesized with
Boc-Phe according to 2.5. 1H-NMR (80 MHz, CDCl3): 1.43 (s, t-Bu); 2.45 (d, CH2); 2.86 (d, CH2); 3.60
(s, MeO); 4.45 (m, CH); 7.25 (s, arom. H).
3. Synthesis of Peptides Containing - and -Amino Acids. Peptides 1, 2, and 3 were synthesized by
conventional solution-phase methods, by means of a fragment condensation strategy. The Boc-group was used
for N-terminal protection, and the C-terminus was protected as a methyl ester. Deprotections were performed
with 98 ± 100% HCOOH and saponification for the N- and C-terminal protecting groups, resp. (monitored by
TLC). Couplings were mediated by DCC/HOBt (1.01 equiv.). All intermediates were characterized by
1H-NMR (80 MHz) and TLC (SiO2, CHCl3/MeOH 9 :1 (v/v)) and were used without further purification. The
final peptides were purified by reversed-phase MPLC (C18-column, 40 ± 60 m, MeOH/H2O 60 :40 ± 95 :5) and
then by reversed-phase HPLC (C18-column, 5 ± 10 m,MeOH/H2O gradients). The homogeneity of the purified
peptides were assertained by anal. HPLC. The purified peptides were characterized by MALDI-TOF-MS and
by assignment of the 500-MHz 1H-NMR spectra.
3.1. Synthesis of Boc-Leu-Val-Val-Pro-Phe-Leu-Val-Val-OMe (1). 3.1.1. Boc-Val-Val-OMe. Boc-Val
(5.4 g, 25mmol) was dissolved in CH2Cl2 (20 ml) and cooled in an ice bath. H-Val-OMe, isolated from 8.4 g
(50 mmol) of H-Val-OMe ¥HCl, was added to the mixture followed by 5.4 g (27 mmol) of DCC. The mixture
was allowed to warm to r.t. and stirred for 6 h. CH2Cl2 was evaporated, and the residue was taken up in 100 ml of
AcOEt. The precipitated dicyclohexyl urea (DCU) was filtered off. The filtrate was washed with 2 HCl (3
50 ml), 5% Na2CO3 (3 50 ml), brine (50 ml), and dried (Na2SO4). The org. layer was evaporated under
reduced pressure to yield 8 g (95%) of Boc-Val-Val-OMe as a white solid. 1H-NMR (80 MHz, CDCl3): 0.95
(m, 4 Me(Val)); 1.46 (s, t-Bu); 2.15 (m, 2 HC()(Val)); 3.7 (s, MeO); 3.85 (m, HC()(Val(1)); 4.5
(m, HC()(Val(2)); 5.0 (d, NH(Val(1)); 6.35 (d, NH(Val(2)).
3.1.2. Boc-Leu-Val-Val-OMe. Boc-Val-Val-OMe (4.9 g, 15 mmol) was deprotected with 60 ml of HCOOH.
After 4 h, HCOOH was evaporated, and the residue was diluted with 100 ml of H2O. The aq. soln. was washed
with Et2O (3 30 ml). The pH of the aq. layer was adjusted to ca. 9.0 with Na2CO3, and the resulting soln. was
extracted with AcOEt (3 50 ml). The combined AcOEt extract was washed with brine (30 ml), dried
(Na2SO4), and concentrated under reduced pressure to ca. 10 ml. The soln. was added to a pre-cooled soln. of
3.7 g (16 mmol) of Boc-Leu in 15 ml of anh. DMF. After coupling (DCC/HOBT), the mixture was kept at r.t. for
16 h. DCUwas filtered off after diluting with 100 ml of AcOEt, and the filtrate was subsequently washed with 2
HCl (3 20 ml), 5%Na2CO3 (3 20 ml), and brine (30 ml). The org. layer was dried (Na2SO4) and evaporated
under reduced pressure to yield 4.6 g (70%) of Boc-Leu-Val-Val-OMe as a white solid. 1H-NMR (80 MHz,
CDCl3): 0.90 (m, 2 Me(Leu) , 4 Me(Val)) ; 1.44 (s, t-Bu) ; 1.56 (m, CH2()(Leu) , HC(Leu)) ; 2.1
(m, 2 HC()(Val)); 3.72 (s, MeO); 4.1 (m, HC()(Leu)); 4.4 (m, 2 HC()(Val)); 5.3 (d, NH(Leu));
6.35 (d, NH(Val)); 6.65 (d, NH(Val)).
3.1.3. Boc-Leu-Val-Val-OH. Boc-Leu-Val-Val-OMe (2.8 g, 6.5 mmol) was dissolved in 25 ml of MeOH, and
14 ml of 1 NaOH was added slowly. After 8 h, MeOH was evaporated under reduced pressure, the residue was
dissolved in 30 ml of H2O and washed with Et2O (3 20 ml). The aq. soln. was cooled in an ice bath, acidified
with 1 HCl to pH 2, and extracted with AcOEt (3 30 ml). The combined AcOEt extract was dried (Na2SO4)
and evaporated to yield 2.6 g (92%) of Boc-Leu-Val-Val-OH as a white solid.
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3.1.4. Boc-Phe-Leu-Val-Val-OMe. Boc-Leu-Val-Val-OMe (2.2 g, 5 mmol) was deprotected with 20 ml of
HCOOH. After 4 h, HCOOH was evaporated, and the residue was diluted with 100 ml of H2O. After aq. work-
up according to 3.1.2, the org. layer was concentrated to ca. 5 ml and was added to a pre-cooled soln. of 1.4 g
(5 mmol) of Boc-Phe in 8 ml of anh. DMF. After coupling (DCC/HOBT), the mixture was kept at r.t. for 20 h.
Workup according to 3.1.2 yielded 2.1 g (70%) of Boc-Phe-Leu-Val-Val-OMe as a white solid. 1H-NMR
(80 MHz, CDCl3): 0.90 (m, 2 Me(Leu), Me(Val)); 1.44 (s, t-Bu); 1.56 (m, CH2()(Leu), HC()(Leu)); 2.1
(m, 2 HC()(Val)) ; 2.42 (d, CH2()(Phe)) ; 2.85 (d, CH2()(Phe)) ; 3.72 (s, MeO); 4.1 ± 4.6
(m, 3 HC()(Leu,Val,Val), HC()(Phe)); 5.3, 6.75, 6.9 (3d, 3 NH); 7.23 (s, 5 arom. H); 7.5 (d, NH).
3.1.5. Boc-DPro-Phe-Leu-Val-Val-OMe. Boc-Phe-Leu-Val-Val-OMe (1.8 g, 3 mmol) was deprotected
with 12 ml of HCOOH. After 4 h, HCOOH was evaporated, and the residue was diluted with 100 ml of H2O.
After aq. workup according to 3.1.2, the org. phase was concentrated to 5 ml and was added to a pre-cooled soln.
of 0.64 g (3 mmol) of Boc-DPro in 5 ml of anh. DMF. After coupling (DCC/HOBT), the mixture was kept at r.t.
for 36 h. Workup according to 3.1.2 yielded 1.35 g (65%) of Boc-DPro-Phe-Leu-Val-Val-OMe as a white solid.
1H-NMR (80 MHz, CDCl3): 0.86 (m, 2 Me(Leu), 4 Me(Val)) ; 1.45 (s, t-Bu); 1.62 (m, CH2()(Leu),
HC()(Leu)); 1.75 ± 2.25 (m, 2 HC()(Val), CH2()(DPro), CH2()(DPro)); 2.45 (d, CH2()(Phe));
2.83 (d, CH2()(Phe)); 3.4 (m, CH2()(DPro)); 3.65 (s, MeO); 4.1 ± 4.5 (m, 4 HC()(Leu,DPro,Val,Val),
HC()(Phe)); 5.5, 6.5, 7.1 (3d, 3 NH); 7.25 (s, 5 arom. H); 7.4 (d, NH).
3.1.6. Boc-Leu-Val-Val-DPro-Phe-Leu-Val-Val-OMe (1) . Boc-DPro-Phe-Leu-Val-Val-OMe (0.6 g,
0.86 mmol) was deprotected with 4 ml of HCOOH. After aq. workup according to 3.1.2, the org. layer was
concentrated to ca. 3 ml and was added to a pre-cooled soln. of 0.37 g (0.86 mmol) of Boc-Leu-Val-Val-OH in
5 ml of anh. DMF. After coupling (DCC/HOBT), the mixture was kept at r.t. for 2 d. Workup was achieved
according to 3.1.2 to give crude 1 (0.6 g, 69%), which was purified by MPLC and then further purified by HPLC.
1H-NMR (500 MHz): see Table 1. MALDI-TOF-MS: 1035.5 ([MNa] , calc. 1012).
3.2. Synthesis of Boc-Leu-Val-Val-DPro-Gly-Leu-Val-Val-OMe (2). 3.2.1. Boc-Leu-Val-Val-OMe. Boc-
Val-Val-OMe (2.6 g, 8 mmol) was deprotected with 32 ml of HCOOH. After 4 h, HCOOH was evaporated, and
the residue was diluted with 100 ml of H2O. After aq. workup according to 3.1.2, the org. layer was concentrated
to ca. 10 ml and was added to a pre-cooled soln. of 1.9 g (8.1 mmol) of Boc-Leu in 10 ml of anh. DMF. After
coupling (DCC/HOBT), the mixture was kept at r.t. for 14 h. Workup according to 3.1.2 yielded 2.7 g (75%) of
Boc-Leu-Val-Val-OMe as a white solid. 1H-NMR (80 MHz, CDCl3): 0.91 (m, 2 Me(Leu), 4 Me(Val)); 1.42
(s, t-Bu); 1.56 ± 1.72 (m, CH2()(Leu), HC()(Leu)); 1.89 (m, 2 HC()(Val)); 2.42 (d, CH2()(Leu));
3.56 (s, MeO); 4.1 ± 4.5 (m, 2 HC()(Val), HC()(Leu)); 5.4, 6.75, 7.32 (3d, 3 NH).
3.2.2. Boc-Leu-Val-Val-OMe. Boc-Val-OMe (1.38 g, 6 mmol) was deprotected with 24 ml of HCOOH.
After 4 h, HCOOH was evaporated, and the residue was diluted with 60 ml of H2O. After aq. workup according
to 3.1.2, the org. layer was concentrated to ca. 10 ml and was added to a pre-cooled soln. of 1.32 g (4 mmol) of
Boc-Leu-Val-OH in 5 ml of anh. DMF. After coupling (DCC/HOBT), the mixture was kept at r.t. for 12 h.
Workup according to 3.1.2 yielded 1.2 g (63%) of Boc-Leu-Val-Val-OMe as a white solid. 1H-NMR (80 MHz,
CDCl3): 0.91 (m, 2 Me(Leu), 2 Me(Val), 2 Me(Val)); 1.44 (s, t-Bu); 1.56 (m, CH2()Leu), HC()(Leu));
2.1 (m, HC()(Val), HC()(Val)); 2.36 (d, CH2()(Val)); 3.62 (s, MeO); 4.1 ± 4.5 (m, HC()(Leu),
HC()(Val), HC()(Val)); 5.6, 6.65, 6.8 (3d, 3 NH).
3.2.3. Boc-DPro-Gly-Leu-Val-Val-OMe. Boc-Leu-Val-Val-OMe (0.9 g, 2 mmol) was deprotected with
10 ml of HCOOH. After 4 h, HCOOHwas evaporated, and the residue was diluted with 50 ml of H2O. After aq.
workup according to 3.1.2, the org. layer was concentrated to ca. 6 ml and was added to a pre-cooled soln. of
0.54 g (2 mmol) of Boc-DPro-Gly [37] in 6 ml of anh. DMF. After coupling (DCC/HOBT), the mixture was kept
at r.t. for 20 h. Workup according to 3.1.2 yielded 0.9 g (75%) of Boc-Leu-Val-Val-OMe as a white solid.
1H-NMR (80 MHz, CDCl3): 0.86 (m, 2 Me(Leu), 4 Me(Val)); 1.42 (s, t-Bu); 1.56 (m, CH2()(Leu),
HC()(Leu)); 1.75 ± 2.25 (m, 2 HC()(Val), CH2()(DPro), CH2()(DPro)); 2.42 (d, CH2()(Leu));
3.4 ± 3.7 (m, CH2()DPro), CH2()(Gly)) ; 3.62 (s, MeO); 4.1 ± 4.5 (m, 3 HC()(DPro,Val,Val) ,
HC()(Leu)); 5.4, 6.55 (2d, 2 NH); 6.85 (m, NH); 7.3 (d, NH).
3.2.4. Boc-Leu-Val-Val-DPro-Gly-Leu-Val-Val-OMe (2). Boc-DPro-Gly-Leu-Val-Val-OMe (0.73 g,
1.2 mmol) was deprotected with 6 ml of HCOOH. After 4 h, HCOOH was evaporated, and the residue was
diluted with 50 ml of H2O. After aq. workup according to 3.1.2, the AcOEt layer was concentrated under
reduced pressure to ca. 3 ml and was added to a pre-cooled soln. of 0.53 g (1.2 mmol) of Boc-Leu-Val-Val-OH
in 6 ml of anh. DMF. After coupling (DCC/HOBT), the mixture was stirred at r.t. for 2 d. Workup according to
3.1.2 gave crude 2 (0.8 g, 72%), which was subjected to MPLC and was further purified by HPLC. 1H-NMR
(500 MHz): see Table 2. MALDI-TOF-MS: 960.8 ([MNa] , calc. 936).
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3.3. Synthesis of Boc-Leu-Val-Phe-Val-DPro-Gly-Leu-Phe-Val-Val-OMe (3). 3.3.1. Boc-Leu-Val-Phe-
Val-OMe. Boc-Phe-Val-OMe (1.54 g, 4 mmol) was deprotected with 12 ml of HCOOH. After 4 h, HCOOH
was evaporated, and the residue was diluted with 80 ml of H2O. After aq. workup according to 3.1.2, the org.
layer was concentrated to ca. 10 ml and was added to a pre-cooled soln. of 1.32 g (4 mmol) of Boc-Leu-Val-OH
in 10 ml of anh. DMF. After coupling (DCC/HOBT), the mixture was kept at r.t. for 24 h. Workup according to
3.1.2 yielded 1.82 g (75%) of Boc-Leu-Val-Phe-Val-OMe as a white solid. 1H-NMR (80 MHz, CDCl3): 0.89
(m, 2 Me(Leu), 4 Me(Val)); 1.42 (s, t-Bu); 1.56 (m, CH2()(Leu), HC()(Leu)); 2.1 (m, 2 HC()(Val));
2.38 (d, CH2()(Phe)) ; 2.85 (d, CH2()(Phe)); 3.62 (s, MeO); 4.1 ± 4.6 (m, 3 HC()(Leu,Val,Val),
HC()(Phe)); 5.3 (d, NH(Leu)); 6.35, 6.65, 6.8 (3d, 3 NH); 7.25 (s, 5 arom. H).
3.3.2. Boc-Leu-Phe-Val-Val-OMe. Boc-Val-Val-OMe (1.65 g, 5 mmol) was deprotected with 20 ml of
HCOOH. After 4 h, HCOOHwas evaporated, and the residue was diluted with 80 ml of H2O. After aq. workup
according to 3.1.2, the org. layer was concentrated to ca. 10 ml and was added to a pre-cooled soln. of 3.7 g
(5.1 mmol) of Boc-Leu-Phe-OH in 15 ml of anh. AcOEt. After coupling (DCC/HOBT), the mixture was kept
at r.t. for 48 h. Workup according to 3.1.2 yielded 2.4 g (80%) of Boc-Leu-Phe-Val-Val-OMe as a white solid.
1H-NMR (80 MHz, CDCl3): 0.86 (m, 2 Me(Leu), 4 Me(Val)) ; 1.44 (s, t-Bu); 1.56 (m, CH2()(Leu),
HC()(Leu)); 2.1 (m, 2 HC()(Val)); 2.42 (d, CH2()(Phe)); 2.85 (d, CH2()(Phe)); 3.65 (s, MeO);
4.1 ± 4.6 (m, 3HC()(Leu,Val,Val), HC()(Phe)); 5.5 (d, NH(Leu)); 6.63, 6.9 (2d, 2 NH), 7.28 (s, 5 ar-
om. H); 7.45 (d, NH).
3.3.3. Boc-DPro-Gly-Leu-Phe-Val-Val-OMe. Boc-Leu-Phe-Val-Val-OMe (2.5 g, 2.5 mmol) was depro-
tected with 10 ml of HCOOH. After 4 h, HCOOH was evaporated and the residue was diluted with 100 ml of
H2O. After aq. workup according to 3.1.2, the org. phase was concentrated to 5 ml and was added to a pre-cooled
soln. of 0.67 g (2.5 mmol) of Boc-DPro-Gly in 10 ml of anh. DMF. After coupling (DCC/HOBT), the mixture
was kept at r.t. for 48 h. Workup according to 3.1.2 yielded 1.9 g (60%) of Boc-DPro-Gly-Leu-Phe-Val-Val-
OMe as a white solid. 1H-NMR (80 MHz, CDCl3): 0.86 (m, 2 Me(Leu), 4 Me(Val)); 1.40 (s, t-Bu); 1.62
(m, CH2()(Leu), HC()(Leu)); 1.74 ± 2.24 (m, 2 HC()(Val), CH2()(DPro), CH2()(DPro)); 2.45
(d, CH2()(Phe)); 2.83 (d, CH2()(Phe)); 3.4 (m, CH2()(DPro), CH2()(Gly)); 3.65 (s, MeO); 4.1 ± 4.5
(m, 4 HC()(Leu,DPro,Val,Val), HC()(Phe)); 5.5, 6.5, 7.1 (3d, 3 NH); 7.25 (s, 5 arom. H); 7.35
(t, NH(Gly)); 7.4 (d, NH).
3.3.4. Boc-Leu-Val-Phe-Val-DPro-Gly-Leu-Phe-Val-Val-OMe (3). Boc-DPro-Gly-Leu-Phe-Val-Val-
OMe (0.75 g, 1 mmol) was deprotected with 4 ml of HCOOH. After 6 h, HCOOH was evaporated, and the
residue was diluted with 120 ml of H2O. After aq. workup according to 3.1.2, the AcOEt layer was concentrated
under reduced pressure to ca. 6 ml and was then added to a pre-cooled soln. of 0.59 g (1 mmol) of Boc-Leu-Val-
Phe-Val-OH in 6 ml of anh. DMF. HOBT (0.16 g, 1.1 mmol) was used for coupling. The mixture was stirred at
r.t. for 3 d. Workup was achieved as described in 3.1.2 to give crude 3 (0.85 g, 70%), which was subjected to
MPLC and was further purified by HPLC. 1H-NMR (500 MHz): see Table 3. MALDI-TOF-MS: 1252.3 ([M
Na] , calc. 1232.5).
3.4. X-Ray Crystallography. Single crystals were obtained by slow evaporation from MeOH. A colorless
crystal in the form of a needle, 0.70 0.20 0.15 mm, coated with microscope oil, was cooled to 60. The
crystal was not stable at that temp. It turned opaque, but recovered at r.t. Hence, X-ray-diffraction data were
collected at r.t. on a Bruker P4 diffractometer. The /2-scan mode was used with a 1.4  2 (1, 2) scan
width, 13/min scan speed and 2max 100 (1.0 ä resol.). The crystal parameters are C47H82N8O11 ¥H2O, space
group C2, a 34.184(5) ä, b 10.673(3) ä, c 18.965(4) ä,  120.440(10), V 5966(2) ä3, 4 molecules/cell,
d 1.061 mg/m3. The number of observed X-ray reflections was rather limited, ca. 35% of the Cu sphere, hence,
not sufficient for direct phase determination for solving the structure. The structure was solved by reducing the
symmetry of the space group to P1 and using a fragment based on the known structure of 3 as a model in a
vector search procedure. It revealed the orientation of the fragment in the cell of 2. Subsequently, the correctly
placed fragment was used in a phase-expansion procedure with the tangent formula [38], alternating with E-
maps to derive the location of the remainder of the atoms. The symmetry elements observed between the two
molecules found in this fashion in space group P1 led to the placement of 2 in space group C2. For 1448
reflections observed with Fo  4.0
, the agreement factor R1 was 8.9%. The least-squares program used was
Siemens SHELXTL, version 5.03 (Iselin, N.J.).
The backbone and side-chain torsion angles and H-bond parameters are summarized in Tables 4 and 5.
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